Search results
5 days ago · Astellas is a company that aims to improve the health of people around the world with innovative and reliable products. Learn about its financial results, R&D strategy, sustainability, partnering opportunities, and latest news.
- Partnering
Why Partner with Astellas We apply a long-term, strategic...
- Careers
Developing innovative therapies is one of the most...
- Suppliers
Here our current and prospective suppliers can find...
- Contact Us
Contact Astellas Pharma Inc. Location: 2-5-1,...
- WORLDWIDE
Poland - Astellas Pharma Sp.zo.o. Portugal - Astellas Farma...
- Registration Form
We have set Med-term Priorities, Initiatives, and Our...
- Newsroom
Thank you for visiting the Astellas Pharma Inc. Website. You...
- Innovation
Astellas believes that application of cutting-edge science &...
- Sustainability
Improving sustainability requires effort, and Astellas...
- About
Thank you for visiting the Astellas Pharma Inc. Website. ......
- Partnering
Astellas Pharma US is a pharmaceutical company that develops and markets products for various diseases and conditions. Learn about its latest news, sponsored research, patient advocacy resources and more.
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd ...
Astellas is a global pharmaceutical company that aims to create innovative healthcare solutions and value for patients. Learn about its history, business, R&D, and diversity goals.
- 103,001 million yen (March 2024)
- 1923
- Astellas Pharma Inc.
May 12, 2023 · Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause. VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause. TOKYO, May 12, 2023 / PRNewswire / -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura ...
We're designing clinical trials that merge Astellas' scientific approach with actual patient needs and experiences, while pushing for diversity in study populations. Our pipeline is continually enrolling, seeking to develop medications for patients with few treatment options.
People also ask
When did Astellas acquire OSI Pharmaceuticals?
Is Astellas a Japanese company?
Who is Astellas Pharma?
How many followers does Astellas Pharma have?
Astellas Pharma is a public company with more than 14,000 employees and business in approximately 70 countries. Follow its LinkedIn page to see its latest updates, news, awards, and insights on healthcare innovation, patient centricity, and more.
